The FDA has removed the REMS requirement for Caprelsa (vandetanib), a kinase inhibitor for medullary thyroid cancer.

Studies evaluate levothyroxine’s impact on cardiovascular disease risk in midlife and older women and in adults with ...

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally ...

Mounjaro and Ozempic are two different drugs to manage type 2 diabetes and weight loss. Know all about their benefits and likely side effects.

A diabetes and endocrine care practice has relocated to a new facility in Lakeway. The overview Bluebonnet Diabetes & ...

A study led by Vincenzo Condello and Christofer Juhlin of the Karolinska Institutet explores why some papillary thyroid ...

Papillary thyroid cancer is the most common form of thyroid cancer, accounting for about 80% of all thyroid cancer diagnoses. It originates from the follicular cells in the thyroid gland, a ...

Thyroid problems are often underdiagnosed because their symptoms mimic many common health issues, making misdiagnosis frequent. Regular check-ups and awareness of risk factors are essential for early ...

PCOS affects up to 13% of women of reproductive age and increases the risk for type 2 diabetes, cardiovascular diseases, ...

A study led by Vincenzo Condello and Christofer Juhlin, has been published in Endocrine Pathology. The researchers explored ...

India embraces GLP-1 medications as a major advance in diabetes and obesity care. Experts warn these drugs require medical ...

The Company’s exhibition booth served as a central hub for leading endocrinologists, surgeons, and researchers from the U.S., ...